Pharmacokinetically guided dose escalation in phase I clinical trials. Commentary and proposed guidelines. EORTC Pharmacokinetics and Metabolism Group

Eur J Cancer Clin Oncol. 1987 Jul;23(7):1083-7. doi: 10.1016/0277-5379(87)90365-8.
No abstract available

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / metabolism
  • Drug Administration Schedule
  • Drug Evaluation
  • Humans
  • Kinetics
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism

Substances

  • Antineoplastic Agents